Evidence map›Paper›PMID 34184982›Full record

ArticleMicrobial genomics2021

Large-scale sequencing of SARS-CoV-2 genomes from one region allows detailed epidemiology and enables local outbreak management.

Andrew J Page, Alison E Mather, Thanh Le-Viet, Emma J Meader, Nabil-Fareed Alikhan, Gemma L Kay, Leonardo de Oliveira Martins, Alp Aydin, David J Baker, Alexander J Trotter and 33 more

Abstract read
In one paragraph

Article in Microbial genomics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

43 authors.

Andrew J PageQuadram Institute Bioscience, Norwich Research Park, Norwich, NR4 7UQ, UK.
Alison E MatherQuadram Institute Bioscience, Norwich Research Park, Norwich, NR4 7UQ, UK.
Thanh Le-VietQuadram Institute Bioscience, Norwich Research Park, Norwich, NR4 7UQ, UK.
Emma J MeaderNorfolk and Norwich University Hospital, Colney Lane, Norwich, NR4 7UY, UK.
Nabil-Fareed AlikhanQuadram Institute Bioscience, Norwich Research Park, Norwich, NR4 7UQ, UK.
Gemma L KayQuadram Institute Bioscience, Norwich Research Park, Norwich, NR4 7UQ, UK.
Leonardo de Oliveira MartinsQuadram Institute Bioscience, Norwich Research Park, Norwich, NR4 7UQ, UK.
Alp AydinQuadram Institute Bioscience, Norwich Research Park, Norwich, NR4 7UQ, UK.
David J BakerQuadram Institute Bioscience, Norwich Research Park, Norwich, NR4 7UQ, UK.
Alexander J TrotterQuadram Institute Bioscience, Norwich Research Park, Norwich, NR4 7UQ, UK.
Steven RudderQuadram Institute Bioscience, Norwich Research Park, Norwich, NR4 7UQ, UK.
Ana P TedimQuadram Institute Bioscience, Norwich Research Park, Norwich, NR4 7UQ, UK.
Anastasia KolyvaQuadram Institute Bioscience, Norwich Research Park, Norwich, NR4 7UQ, UK.
Rachael StanleyNorfolk and Norwich University Hospital, Colney Lane, Norwich, NR4 7UY, UK.
Muhammad YasirQuadram Institute Bioscience, Norwich Research Park, Norwich, NR4 7UQ, UK.
Maria DiazQuadram Institute Bioscience, Norwich Research Park, Norwich, NR4 7UQ, UK.
Will PotterNorfolk and Norwich University Hospital, Colney Lane, Norwich, NR4 7UY, UK.
Claire StuartNorfolk and Norwich University Hospital, Colney Lane, Norwich, NR4 7UY, UK.
Lizzie MeadowsQuadram Institute Bioscience, Norwich Research Park, Norwich, NR4 7UQ, UK.
Andrew BellQuadram Institute Bioscience, Norwich Research Park, Norwich, NR4 7UQ, UK.
Ana Victoria GutierrezQuadram Institute Bioscience, Norwich Research Park, Norwich, NR4 7UQ, UK.
Nicholas M ThomsonQuadram Institute Bioscience, Norwich Research Park, Norwich, NR4 7UQ, UK.
Evelien M AdriaenssensQuadram Institute Bioscience, Norwich Research Park, Norwich, NR4 7UQ, UK.
Tracey SwinglerUniversity of East Anglia, Norwich Research Park, Norwich, NR4 7TJ, UK.
Rachel A J GilroyQuadram Institute Bioscience, Norwich Research Park, Norwich, NR4 7UQ, UK.
Luke GriffithUniversity of East Anglia, Norwich Research Park, Norwich, NR4 7TJ, UK.
Dheeraj K SethiNorfolk and Norwich University Hospital, Colney Lane, Norwich, NR4 7UY, UK.
Dinesh AggarwalPublic Health England, 61 Colindale Ave., London, NW9 5EQ, UK.
Colin S BrownPublic Health England, 61 Colindale Ave., London, NW9 5EQ, UK.
Rose K DavidsonUniversity of East Anglia, Norwich Research Park, Norwich, NR4 7TJ, UK.
Robert A KingsleyQuadram Institute Bioscience, Norwich Research Park, Norwich, NR4 7UQ, UK.
Luke BedfordIpswich Hospital, Heath Road, Ipswich, IP4 5PD, UK.
Lindsay J CouplandNorfolk and Norwich University Hospital, Colney Lane, Norwich, NR4 7UY, UK.
Ian G CharlesQuadram Institute Bioscience, Norwich Research Park, Norwich, NR4 7UQ, UK.
Ngozi ElumogoQuadram Institute Bioscience, Norwich Research Park, Norwich, NR4 7UQ, UK.
John WainQuadram Institute Bioscience, Norwich Research Park, Norwich, NR4 7UQ, UK.
Reenesh PrakashNorfolk and Norwich University Hospital, Colney Lane, Norwich, NR4 7UY, UK.
Mark A WebberQuadram Institute Bioscience, Norwich Research Park, Norwich, NR4 7UQ, UK.
S J Louise SmithPublic Health, County Hall, Martineau Lane, Norwich, NR1 2DH, UK.
Meera ChandPublic Health England, 61 Colindale Ave., London, NW9 5EQ, UK.
Samir DervisevicNorfolk and Norwich University Hospital, Colney Lane, Norwich, NR4 7UY, UK.
Justin O'GradyQuadram Institute Bioscience, Norwich Research Park, Norwich, NR4 7UQ, UK.
The Covid-Genomics Uk Cog-Uk Consortium

Funding

Biotechnology and Biological Sciences Research Council BBS/E/F/000PR10353Biotechnology and Biological Sciences Research Council BBS/E/F/000PR10356Medical Research Council MC_PC_19027Wellcome Trust
6 · The paper itself

Abstract

The COVID-19 pandemic has spread rapidly throughout the world. In the UK, the initial peak was in April 2020; in the county of Norfolk (UK) and surrounding areas, which has a stable, low-density population, over 3200 cases were reported between March and August 2020. As part of the activities of the national COVID-19 Genomics Consortium (COG-UK) we undertook whole genome sequencing of the SARS-CoV-2 genomes present in positive clinical samples from the Norfolk region. These samples were collected by four major hospitals, multiple minor hospitals, care facilities and community organizations within Norfolk and surrounding areas. We combined clinical metadata with the sequencing data from regional SARS-CoV-2 genomes to understand the origins, genetic variation, transmission and expansion (spread) of the virus within the region and provide context nationally. Data were fed back into the national effort for pandemic management, whilst simultaneously being used to assist local outbreak analyses. Overall, 1565 positive samples (172 per 100 000 population) from 1376 cases were evaluated; for 140 cases between two and six samples were available providing longitudinal data. This represented 42.6 % of all positive samples identified by hospital testing in the region and encompassed those with clinical need, and health and care workers and their families. In total, 1035 cases had genome sequences of sufficient quality to provide phylogenetic lineages. These genomes belonged to 26 distinct global lineages, indicating that there were multiple separate introductions into the region. Furthermore, 100 genetically distinct UK lineages were detected demonstrating local evolution, at a rate of ~2 SNPs per month, and multiple co-occurring lineages as the pandemic progressed. Our analysis: identified a discrete sublineage associated with six care facilities; found no evidence of reinfection in longitudinal samples; ruled out a nosocomial outbreak; identified 16 lineages in key workers which were not in patients, indicating infection control measures were effective; and found the D614G spike protein mutation which is linked to increased transmissibility dominates the samples and rapidly confirmed relatedness of cases in an outbreak at a food processing facility. The large-scale genome sequencing of SARS-CoV-2-positive samples has provided valuable additional data for public health epidemiology in the Norfolk region, and will continue to help identify and untangle hidden transmission chains as the pandemic evolves.

Indexed as

Genome, ViralCluster AnalysisCOVID-19Disease OutbreaksGenetic LinkageHumansLongitudinal StudiesPandemicsPhylogenyPolymorphism, Single NucleotideSARS-CoV-2Spike Glycoprotein, CoronavirusUnited KingdomWhole Genome SequencingSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2ARTICgenomegenomic epidemiologyNGSSARS-CoV-2sequencing

Identifiers

PMID34184982
PMCPMC8461472

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.